Read-across of 90-day rodent repeated-dose toxicity: A case study for selected simple aryl alcohol alkyl carboxylic acid esters by Firman, J et al.
 Firman, J, Patel, A, Date, M, Cronin, MTD and Schultz, TW
 Read-across of 90-day rodent repeated-dose toxicity: A case study for 
selected simple aryl alcohol alkyl carboxylic acid esters
http://researchonline.ljmu.ac.uk/id/eprint/8648/
Article
LJMU has developed LJMU Research Online for users to access the research output of the 
University more effectively. Copyright © and Moral Rights for the papers on this site are retained by 
the individual authors and/or other copyright owners. Users may download and/or print one copy of 
any article(s) in LJMU Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities or 
any commercial gain.
The version presented here may differ from the published version or from the version of the record. 
Please see the repository URL above for details on accessing the published version and note that 
access may require a subscription. 
For more information please contact researchonline@ljmu.ac.uk
http://researchonline.ljmu.ac.uk/
Citation (please note it is advisable to refer to the publisher’s version if you 
intend to cite from this work) 
Firman, J, Patel, A, Date, M, Cronin, MTD and Schultz, TW (2018) Read-
across of 90-day rodent repeated-dose toxicity: A case study for selected 
simple aryl alcohol alkyl carboxylic acid esters. Computational Toxicology, 
7. pp. 1-8. ISSN 2468-1113 
LJMU Research Online
1 
 
Read-across of 90-day rodent repeated-dose toxicity: A case study for selected simple aryl 1 
alcohol alkyl carboxylic acid esters 2 
James W. Firmana,*, Atish Patelb, Mihir Dateb, Mark T.D. Cronina, Terry W. Schultzc 3 
 4 
a Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, United Kingdom 5 
b Research Institute of Fragrance Materials, Inc., 50 Tice Boulevard, Woodcliff Lake, NJ 07677, USA 6 
c The University of Tennessee, College of Veterinary Medicine, 2407 River Drive, Knoxville, TN 378996-4543, USA 7 
 8 
* Corresponding author. 9 
E-mail address: j.w.firman@ljmu.ac.uk (James W. Firman). 10 
 11 
Postal address: 12 
 13 
James Firman 14 
School of Pharmacy and Biomolecular Sciences 15 
Liverpool John Moores University 16 
Byrom Street 17 
Liverpool  18 
L3 3AF  19 
United Kingdom 20 
 21 
Disclaimer: The views expressed in this document are those of the authors and do not necessarily 22 
represent the official views of the Research Institute of Fragrance Materials or its members. 23 
 24 
Word Count for Abstract: 167 words 25 
Word Count for Text: 6195 words 26 
Word Count for References: 1344 words 27 
  28 
2 
 
Abstract 29 
 30 
Aryl alcohol alkyl carboxylic acid esters constitute a wide-employed class of fragrance materials. 31 
Outcomes presented within this study illustrate formulation of a read-across protocol for 90-day, 32 
repeat-dose toxicity within a series of these compounds, extending in scope to the dodecanoic acid 33 
esters of both benzyl and 2-phenylethyl alcohol. Central to the filling of data gaps is the hypothesis 34 
that adverse impact – mediated through mechanisms analogous to narcosis-associated non-specific 35 
basal cytotoxicity – is as a consequence of the hydrolysis of parent compounds to their 36 
corresponding alcohol. High-quality in vivo data (equivalent to either OECD Test Guideline 408 or 37 
411) relating the toxicodynamic and toxicokinetic profiles of benzyl alcohol, 2-phenylethyl alcohol 38 
and benzyl acetate within rodents were retrieved, permitting extrapolation to each ester derivative 39 
with great confidence. NOAEL values of 250-500 mg/kg/day were assigned to esters, with a greater 40 
toxicity present within females. In order to greater enhance reliability, further theoretical support 41 
for the read-across prediction is provided through the integration, where appropriate, of in vitro and 42 
in silico data. 43 
 44 
Keywords: aryl alcohol alkyl carboxylic acid esters, read-across, similarity, uncertainty, repeated-45 
dose toxicity 46 
  47 
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Highlights: 48 
 A read-across category including C2 to C12 benzyl and 2-phenylethyl alcohol alkyl carboxylic 49 
acid esters. 50 
 Hydrolysis forms toxicants, benzyl or 2-phenylethyl alcohol, which possess non-specific 51 
narcosis-associated mode of action. 52 
 NOAEL values of 250-500 mg/kg/day can be read across with confidence as a worst-possible 53 
scenario to untested compounds. 54 
 Uncertainty is reduced by the consistency within the category of in vivo, in vitro and in silico 55 
data. 56 
  57 
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1. Introduction 58 
 59 
1.1. Read-across  60 
 61 
Underpinning the concept of toxicological read-across is the principle that chemical compounds 62 
which have similar molecular structures will have a similar toxicodynamic and toxicokinetic profile.[1] 63 
Accordingly, given the availability of experimentally-derived toxicological data for one or more 64 
source compounds, the corresponding activity of untested, structurally-related target compounds 65 
might be rationally inferred and predicted.[2] As research in toxicology continues to trend away from 66 
the methods employing widespread use of animals – notably, but not entirely, within the field of 67 
cosmetic ingredient testing – the requirement for robust, alternative means to fill gaps in safety data 68 
grows more acute. 69 
Read-across methodology has for decades been employed across industry, academia and within 70 
regulatory settings.[3] The anticipated increased future reliance upon it as a predictive tool has 71 
ensured that more thorough, systematic approaches to chemical category formation, analogue 72 
identification and data interpretation need be devised and evaluated.[4] In order to formulate a 73 
robust, comprehensive read-across protocol, a series of case studies were undertaken by the 74 
authors, covering varying scenarios with regard to the relevance of metabolism to toxicity.[5, 6] These 75 
have provided suitable illustrations on how strong, sound groupings can be built considering the 76 
structural, physicochemical, toxicodynamic and toxicokinetic properties of compounds and address, 77 
in part at least, some of the concerns raised by historical studies.[7] 78 
The aim of this study was to further extend the applicability of the principles established in the 79 
previous read-across studies to permit read-across assessment of sub-chronic, repeat-dose toxicity 80 
within a series of aryl alcohol alkyl carboxylic acid esters.[5-7] It relates to two separate, but 81 
structurally-related, categories: the alkanoates of benzyl alcohol and 2-phenylethyl alcohol. Through 82 
consideration of shared mechanistic features between compounds – most notably the metabolic 83 
5 
 
biotransformation to shared toxicophoric species – a robust case for read-across was presented. 84 
Relevant toxicokinetic and toxicodynamic data were searched for, with a focus on no-observed-85 
adverse-effect level (NOAEL) values derived from 90-day rat and mouse studies supported by in vivo 86 
and in vitro metabolic assessment. The read-across arguments were assessed and evaluated by a 87 
discussion of appropriate concerns associated with uncertainty and the weight of evidence 88 
supporting the claims, in accordance with Organisation for Economic Co-operation and Development 89 
(OECD) Integrated Approaches for Testing (IATA) guidelines.[8] 90 
 91 
1.2. Aryl alcohol alkyl carboxylic acid esters: overview of existing knowledge 92 
Owing to their utility as fragrance materials, alkyl carboxylic esters of aryl alcohols are used widely 93 
within cosmetic preparations.[9] Whilst the acute toxicity of selected benzyl and 2-phenylethyl 94 
alkanoates is well characterised, corresponding assessment into the effects of repeat-dose, sub-95 
chronic exposure has been limited.[10, 11] It has been established, however, that such compounds, in 96 
common with many related forms of carboxylic acid ester, undergo rapid and near-complete 97 
hydrolysis. This metabolism occurs  through the action of broad-specification hydrolase enzymes and 98 
yields their alcohol and acid substituents (illustrated with reference to formation of benzyl alcohol 99 
and acetic acid from benzyl acetate, Figure 1.).[12, 13] Accordingly, it can be postulated that their toxic 100 
effects derive solely as a product of their metabolites, and that, given knowledge of the properties of 101 
such compounds, the toxicological profiles of untested esters across a category might be inferred. 102 
  103 
Figure 1. Simplified scheme outlining enzyme-mediated hydrolysis of benzyl acetate to yield aryl alcohol and 104 
alkyl carboxylic acid constituents. 105 
 106 
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The aryl alcohols resulting from metabolism from their alkyl carboxylic esters are associated with 107 
toxicity.[6] Mechanisms underpinning acute toxicity are believed to be analogous with the widely 108 
accepted concept of non-polar narcosis in environmental species. Broadly speaking, this mechanism 109 
centres upon non-specific disruption of cellular membranes, in turn affecting their integrity.[14, 15] In 110 
the same manner, appreciation of sub-chronic effects may be achieved by their consideration in the 111 
context of a framework of repeat-dose “basal cytotoxicity”.[16]  The carboxylic acid moiety, on 112 
account of ready catabolism and integration into physiological pathways, is conversely deemed to 113 
not to contribute towards toxicity. Given the immediacy of hydrolysis, the physicochemical 114 
attributes of the esters, which vary reliably and predictably with alkyl chain length from C2 to C12, 115 
are thought to be of only minor relevance with regards to their toxicokinetic profiles. It can, 116 
nevertheless, be considered reasonable to assume that absorption characteristics, particularly with 117 
respect to dermal administration, will display some degree of variance attributable to the 118 
heightened hydrophobicity of the compounds with longer alkyl chain lengths. 119 
It therefore follows that although suitable in vivo sub-chronic, repeat-dose toxicological data may 120 
exist only for a single aryl alcohol alkyl ester within the category, the properties of analogues can be 121 
predicted reliably based upon extrapolation of corresponding results both from the source 122 
compound and also from the shared aryl alcohol constituent. NOAEL values are available from 123 
repeat-dose 90-day rodent studies both for benzyl alcohol and benzyl acetate, and they are thus 124 
proposed for use in inferring the corresponding quantities in a wider set of benzyl alcohol alkyl 125 
esters extending, for the purposes of this assessment, to benzyl dodecanoate.[17, 18] Similarly, an 126 
experimental sub-chronic NOAEL for 2-phenylethyl alcohol exists within the literature, and this might 127 
be employed for the same purpose within a category of 2-phenylethyl alkanoates, even in the 128 
absence of equivalent data for any such individual compound.[19] As implied above, it is anticipated 129 
that owing to shared structural features between categories, their metabolic profile and 130 
toxicodynamic impact will show great concordance. The lack of experimental, repeat-dose data for 131 
many compounds under consideration nevertheless ensures that is prudent, taking into account the 132 
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shared mechanism of metabolism to the alcohol toxicophore, to adopt a “worst-case” approach in 133 
assigning toxicological properties to targets. 134 
 135 
ID Name CAS No. SMILES 
Benzyl alkanoate    
1 Benzyl acetate 140-11-4 c1ccccc1COC(=O)C 
2 Benzyl propionate 122-63-4 c1ccccc1COC(=O)CC 
3 Benzyl butyrate 103-37-7 c1ccccc1COC(=O)CCC 
4 Benzyl isobutyrate 103-28-6 c1ccccc1COC(=O)C(C)C 
5 Benzyl valerate 10361-39-4 c1ccccc1COC(=O)CCCC 
6 Benzyl isovalerate 103-38-8 c1ccccc1COC(=O)CC(C)C 
7 Benzyl hexanoate 6938-45-0 c1ccccc1COC(=O)CCCCC 
8 Benzyl heptanoate 5454-21-7 c1ccccc1COC(=O)CCCCCC 
9 Benzyl octanoate 10276-85-4 c1ccccc1COC(=O)CCCCCCC 
10 Benzyl nonanoate 6471-66-5 c1ccccc1COC(=O)CCCCCCCC 
11 Benzyl decanoate 42175-41-7 c1ccccc1COC(=O)CCCCCCCCC 
12 Benzyl undecanoate Not found c1ccccc1COC(=O)CCCCCCCCCC 
13 Benzyl dodecanoate 140-25-0 c1ccccc1COC(=O)CCCCCCCCCCC 
14 Benzyl alcohol 100-51-6 c1ccccc1CO 
2-Phenylethyl alkanoate    
15 
16 
2-Phenylethyl acetate 
2-Phenylethyl propionate 
103-45-7 
122-70-3 
c1ccccc1CCOC(=O)C 
c1ccccc1CCOC(=O)CC 
17 2-Phenylethyl butyrate 103-52-6 c1ccccc1CCOC(=O)CCC 
18 2-Phenylethyl isobutyrate 103-48-0 c1ccccc1CCOC(=O)C(C)C  
19 2-Phenylethyl valerate 7460-74-4 c1ccccc1CCOC(=O)CCCC  
20 2-Phenylethyl isovalerate 140-26-1 c1ccccc1CCOC(=O)CC(C)C 
21 2-Phenylethyl hexanoate 6290-37-5 c1ccccc1CCOC(=O)CCCCC 
22 2-Phenylethyl heptanoate 5454-11-5 c1ccccc1CCOC(=O)CCCCCC 
23 
24 
2-Phenylethyl octanoate 
2-Phenylethyl nonanoate 
5457-70-5 
57943-67-6 
c1ccccc1CCOC(=O)CCCCCCC 
c1ccccc1CCOC(=O)CCCCCCCC 
25 2-Phenylethyl decanoate 61810-55-7 c1ccccc1CCOC(=O)CCCCCCCCC 
26 2-Phenylethyl undecanoate Not found c1ccccc1CCOC(=O)CCCCCCCCCC 
27 2-Phenylethyl dodecanoate Not found c1ccccc1CCOC(=O)CCCCCCCCCCC 
28 2-Phenylethyl alcohol 60-12-8 c1ccccc1CCO 
Table 1. Aryl alcohol alkyl carboxylic acid esters considered in this study, grouped within read-across categories 136 
alongside their shared aryl alcohol substituent. Further description of these compounds, including their 137 
chemical structures and molecular formulae, are listed in Supplementary Table 1. 138 
 139 
 140 
 141 
 142 
 143 
 144 
 145 
 146 
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2. Method and materials 147 
 148 
Compounds were evaluated through a read-across protocol drawing extensively on the workflows 149 
proposed by Schultz et al. and Przybylak et al.[5, 6, 20] Analysis was further expanded to include 150 
consideration of the categories under existing OECD IATA guidelines.[8] Relevant in vivo data were 151 
accrued from literature sources, including the ECHA REACH Registered Substances database.[21] 152 
Mechanistic relevance, alongside toxicokinetic and toxicodynamic similarity of the category 153 
analogues, was established using appropriate non-animal data. 154 
 155 
2.1. Source compounds and category members 156 
Two structurally related categories were considered within this study, each consisting of 13 aryl 157 
alcohol alkyl carboxylic acid esters and a single parent aryl alcohol. The members of each category 158 
are detailed in Table 1. Within the benzyl alcohol ester category, two source compounds – benzyl 159 
alcohol and benzyl acetate – were identified based upon the availability of repeat-dose in vivo data. 160 
The 2-phenylethyl ester category similarly comprised two source compounds: 2-phenylethyl alcohol 161 
and 2-phenylethyl acetate. Whilst in vitro toxicokinetic data were present in this instance for the 162 
ester, toxicodynamic outcomes were not. 163 
 164 
2.2. Endpoint 165 
The endpoint for this read-across was repeat-dose, sub-chronic toxicity. This was assessed using data 166 
from protocols equivalent either to OECD Test Guideline 408 (Repeated Dose 90-Day Oral Toxicity 167 
Study, Rodents) or to OECD Test Guideline 411 (Sub-chronic Dermal Toxicity: 90-day Study).[22, 23] 168 
NOAEL values assigned from these reports provided the quantitative expression of toxic potency. In 169 
the instance of a single source compound (benzyl acetate), further supporting evidence was 170 
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provided through a procedure performed in line with the United States’ National Toxicological 171 
Program (NTP) carcinogenicity 2-year study guidelines.[18] 172 
 173 
2.3. Similarity hypothesis for category formation  174 
 Aryl alcohol unsaturated alkyl esters constitute a class of indirect toxicants, the activity of 175 
which is dependent exclusively upon narcosis-related unspecific basal toxicity as induced 176 
through their aryl alcohol hydrolysis products. 177 
 Owing to the rapid nature of hydrolysis, the varying intra-category physicochemical 178 
properties of the compounds, dictated solely by the length of the alkyl chain (from C2 to 179 
C12), hold minor, albeit not negligible with respect to absorption, toxicological relevance. 180 
 Nevertheless, an absence of data for many esters ensures that uncertainty exists regarding 181 
the precise impact of the incremental variation in molecular structure upon quantitative 182 
toxicological outcome – as such, a “worst-case” approach may be adopted to infer 183 
properties from the source esters and, where necessary, alcohols. 184 
 The toxic profiles of the each of the benzyl alcohol esters can be inferred from those of 185 
benzyl alcohol, and the 2-phenylethyl alcohol esters from 2-phenylethyl alcohol, and, where 186 
appropriate, also benzyl acetate. 187 
 Similarity in physicochemical and toxicological properties between alcohols permits cross-188 
category inference of effects in the absence of relevant data. 189 
 Carboxylic acid metabolites exert no contribution towards toxicity, being primarily 190 
catabolised to substrates which participate with various physiological energy-producing 191 
pathways. 192 
 193 
 194 
 195 
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 196 
3. Results and discussion3.1. Compilation of data 197 
Data were accrued from relevant sources in accordance with the methodology outlined in Section 2. 198 
Tables detailing in full the structure and identity of the category members, alongside their 199 
experimentally-derived physicochemical (Supplementary Table 2), toxicodynamic (Table 2 and 200 
Supplementary Table 3) and toxicokinetic properties (Supplementary Table 4), are provided. A 201 
discussion of the recovered toxicodynamic and toxicokinetic outcomes is presented below: 202 
3.1.1. Benzyl acetate 203 
Several assessments have been conducted examining the repeated-dose toxicological profile of 204 
benzyl acetate in vivo. Male and female F344 rats, dosed for a period of 13 weeks via gavage with 0, 205 
62.5, 125, 250, 500 and 1000 mg/kg/day test compound, were observed for clinically relevant 206 
signs.[18] Combined with reduced body weight, evidence of ataxia in tremor in higher-dose groups 207 
prompted the assignment of values for NOAEL of 500 mg/kg/day (males) and 250 mg/kg/day 208 
(females). 209 
A similar study was performed in B6C3F1 mice. Gavage administration of 0, 62.5, 125, 250, 500 and 210 
1000 mg/kg/day benzyl acetate (males) and 0, 125, 250, 500, 1000, 2000 mg/kg/day benzyl acetate 211 
(females) proceeded for 13 weeks.[18] Tremor, inactivity and lowered body temperature were 212 
evident at higher doses in both sexes, with mortality in females being notably elevated. NOAEL was 213 
universally determined as 500 mg/kg/day. 214 
A concurrent 2-year carcinogenicity analysis utilising identical species and strains yielded negative 215 
results at all doses examined (up to 250 mg/kg/day in rats, 500 mg/kg/day in mice).[18] 216 
3.1.2. Benzyl alcohol 217 
In a 13-week study, male and female F344/N rats were administered benzyl alcohol by gavage at 218 
concentrations of 0, 50, 100, 200, 400 or 800 mg/kg/day.[17] Mortality was evident within the 800 219 
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mg/kg/day cohort, with surviving animals exhibiting a variety of clinical signs including staggering 220 
and respiratory dysfunction (indicative of neurotoxicity), localised haemorrhaging and histological 221 
abnormality. Decreased body mass was further apparent in many of the dosed groups. B6C3F1 mice 222 
treated under identical experimental conditions were subject to a similar pattern of effects, albeit 223 
with mortality evident across a wider dose range. Each species was assigned a NOAEL of 100 224 
mg/kg/day. 225 
3.1.3. 2-Phenylethyl alcohol 226 
A 13-week study assessed the impact of dermally-administered 2-phenylethyl alcohol upon male and 227 
female Sprague-Dawley rats.[19] Doses of 0, 0.25, 0.5, 1.0 and 2.0 ml/kg/day (corresponding 228 
approximately to 250, 500, 1000 and 2000 mg/kg/day) were provided. On account of body weight 229 
abnormalities observed at the higher concentrations, a NOAEL of 0.50 ml/kg/day (500 mg/kg/day) 230 
was assigned. 231 
3.1.4. Saturated short- to medium-chain carboxylic acids 232 
The repeat-dosed toxicity of propionic acid has been examined in male and female Sprague-Dawley 233 
rats.[24] Animals were exposed to the compound through their diet for a period of 13 weeks, at 234 
concentrations of 0, 0.62%, 1.25%, 2.5% or 5.0% (approximating to 312, 625, 1250 or 2500 235 
mg/kg/day). A minor decrease in body weight was apparent within the higher-dose male group, with 236 
a 12% reduction in kidney size being the most notable single-organ alteration. High-dose females 237 
displayed increased mass in heart and liver. Neither sex exhibited histological abnormalities, and 238 
lesions were observed only within forestomach mucosa. NOAEL values were assigned as 1250 239 
mg/kg/day and 2500 mg/kg/day for males and females respectively. 240 
A 13-week assessment of isovaleric acid toxicity was performed in male Sprague-Dawley rats.[25] 241 
Neutralised isovaleric acid was incorporated into the diet at concentrations of 0, 5% and 10% 242 
(approximately corresponding to 0, 5000 and 10000 mg/kg/day). Whilst a single instance of 243 
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mortality was observed at the highest dose, no instances of unusual histopathological or gross effect, 244 
aside from alkalisation of urine, were noted at 5%. The NOAEL can thus be considered to be 5000 245 
mg/kg/day. 246 
Dodecanoic acid was analysed for toxic effects in male and female Osborne-Mendel rats.[26] Test 247 
animals were administered the carboxylic acid in their diet over a period of 18 weeks, at 248 
concentrations 0 and 10% (approximating to 10000 mg/kg/day). No clinical effects were observed 249 
across all parameters examined, ensuring that a NOAEL of 10000 mg/kg/day could be attributed. 250 
 251 
Compound 
NOAEL (mg/kg/day) 
Rat Mouse 
Male Female Male Female 
     
Benzyl acetate 500 250 500 500 
Benzyl propionate 500 250 500 500 
Benzyl butyrate 500 250 500 500 
Benzyl isobutyrate 500 250 500 500 
Benzyl valerate 500 250 500 500 
Benzyl isovalerate 500 250 500 500 
Benzyl hexanoate 500 250 500 500 
Benzyl heptanoate 500 250 500 500 
Benzyl octanoate 500 250 500 500 
Benzyl nonanoate 500 250 500 500 
Benzyl decanoate 500 250 500 500 
Benzyl undecanoate 500 250 500 500 
Benzyl dodecanoate 500 250 500 500 
Benzyl alcohol 100 100 100 100 
     
2-Phenylethyl acetate 500 500   
2-Phenylethyl propionate 500 500   
2-Phenylethyl butyrate 500 500   
2-Phenylethyl isobutyrate 500 500   
2-Phenylethyl valerate 500 500   
2-Phenylethyl isovalerate 500 500   
2-Phenylethyl hexanoate 500 500   
2-Phenylethyl heptanoate 500 500   
2-Phenylethyl octanoate 500 500   
2-Phenylethyl nonanoate 500 500   
2-Phenylethyl decanoate 500 500   
2-Phenylethyl undecanoate 500 500   
2-Phenylethyl dodecanoate 500 500   
2-Phenylethyl alcohol 500 500   
Table 2. Summary of NOAEL values, both experimental and inferred. Quantities in bold print correspond to 252 
experimentally-determined 90-day NOAEL. Those in italics represent values read across in instances of data 253 
absence. 254 
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3.2. Justification of read-across 255 
The acceptance of the validity of a read-across hypothesis is dependent not solely upon 256 
identification of shared structural features between source and target compound, but also on 257 
establishing their similarity in physicochemical, metabolic, toxicodynamic and toxicokinetic 258 
properties.[20] It is furthermore a requirement that a firm rationale for mechanistic plausibility be 259 
developed and supported. Accordingly, relevant concordance and variation within such parameters 260 
across the ester categories are outlined and considered: 261 
3.2.1. Applicability domain 262 
The applicability domain of the study incorporates the alkyl esters of benzyl and 2-phenylethyl 263 
alcohol, possessing chain lengths on the carboxylic acid moiety of C2 to C12. 264 
3.2.2. Structural Similarity 265 
All aryl alcohol esters considered display substantial structural similarity. Notably, they belong: (1) to 266 
a common chemical class in the form of carboxylate esters and (2) the subclass of primary aryl 267 
alcohol alkyl esters. Variability in structure within category is limited to the composition of alkyl 268 
chain, which ranges in length from 2 to 12 carbon atoms. Between categories, the length of carbon 269 
linker adjoining the aromatic unit varies from 1 to 2 carbon atoms. Accordingly, the composition of 270 
the toxic aryl alcohol metabolite exhibits only very minor inter-category variation. 271 
3.2.3. Chemical property similarity 272 
The physicochemical properties for each respective category member are reported in 273 
Supplementary Table 2. Experimentally-derived quantities are used as available, although for the 274 
great majority of the aryl alcohol esters such parameters were not available. Accordingly, predicted 275 
values for physicochemical properties were employed where appropriate. Data pertaining the 276 
relevant carboxylic acids, predominantly experimental in source, are included for completeness. It 277 
can be observed that there is, across all properties with the sole exception of density, an intra-278 
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category variance correlated strongly with alkyl chain length and molecular size. The molecular 279 
weights of the esters range from 150.2 to 304.5. With increasing molecular mass comes increase in 280 
the logarithm of the octanol-water partition coefficient (log KOW), melting point and boiling point, 281 
and a concurrent decrease in water solubility and vapour pressure. 282 
3.2.4. Chemical constituent similarity 283 
All aryl alcohol alkyl esters included within this analysis contain common constituents limited to: (1) 284 
a polar aliphatic ester functional unit, -[COC(=O)]-, (2) aliphatic secondary and primary carbon -285 
[CH2]- and -[CH3] structural fragments, and (3) aromatic carbon -[CH]-. Also present on branched 286 
substituents is the tertiary aliphatic carbon -[CH]-. Primary aryl alcohols are each composed of: (1) a 287 
polar functional substituent -[OH], (2) the aliphatic secondary carbon fragment -[CH2]- and (3) the 288 
aromatic carbon unit -[CH]-. Alkyl carboxylic acids are constituted from (1) the polar aliphatic 289 
carboxylic acid functional moiety [OC(=O)]- and (2) the structural fragments aliphatic secondary and 290 
primary carbon -[CH2]- and -[CH3]. Also present on branched substituents is the tertiary aliphatic 291 
carbon -[CH]-. 292 
3.2.5. Toxicokinetic similarity  293 
Whilst experimental toxicokinetic data are not available for all the esters considered within this 294 
study, the premise upon which their activity is believed to rest – namely, metabolism to toxicophoric 295 
aryl alcohol and non-toxic alkyl carboxylic acid species – can be considered conserved across all 296 
category members. Generally, such compounds are rapidly absorbed, distributed via the blood, 297 
metabolised and excreted. As compared with dermal exposure, there is evidence of more extensive 298 
absorption from the gut. In the latter case, toxicokinetic potency is greater via gavage than through 299 
dosed feed administration. The results of studies of ester hydrolysis in vitro indicate it to be a 300 
universal metabolic step.[27, 28] The hydrolysis rate of straight-chain esters is approximately 100 times 301 
greater than that of their branched-chain counterparts.[29] Select isoenzymes exhibit an increase in 302 
15 
 
enzyme binding (lower Km) and maximum velocity (Vmax) as the carbon chain length of either the 303 
alcohol or carboxylic acid component of the substrate increases.[12] 304 
Evidence pertaining to the in vivo metabolic profile of benzyl acetate suggests that hydrolysis of the 305 
parent compound proceeds rapidly, yielding substrates which undergo ready conjugation and 306 
elimination. The outcomes of oral administration studies in both rats and mice indicate that 307 
formation of benzyl alcohol occurs as an initial step.[30] Oxidation of this compound, through a 308 
benzaldehyde intermediate, to benzoic acid is followed by conjugation with glycine, creating 309 
hippuric acid. It is this which ultimately constitutes the dominant metabolite present within urine.[31] 310 
The toxicokinetics of 14C-radiolabelled benzyl acetate following dermal application have been 311 
examined further in rats. 28-46% of the administered dose was absorbed into the circulation, of 312 
which 95% was excreted in urine within 24 hours of dosing. Hippuric acid was once again found to be 313 
the principal species expelled, accounting for 95% of metabolites detected.[32] Dedicated 314 
examinations of the fate of benzyl alcohol have been performed in several species, with consistency 315 
in disposition displayed in each.[33] Within rabbits, 65.7% of an oral dose was found eliminated in 316 
urine as hippuric acid within 6 hours of treatment.[34] 317 
Whilst in vivo assessment of 2-phenylethyl acetate toxicokinetics have not been reported, evidence 318 
derived from in vitro studies, utilising both rat liver and intestine tissue samples and artificial gastric 319 
juices, strongly indicates that the ester readily undergoes hydrolysis to its constituent alcohol and 320 
acid.[27] The properties of 2-phenylethyl alcohol have been subject to extensive in vivo examination, 321 
with the compound displaying rapid absorption within both rabbits and rats.[35] Rat studies 322 
demonstrate that 70% of the dose may be recovered following oral administration – predominantly 323 
in the form of 2-phenylethylacetic acid and its conjugates.[36] Recovery following topical application 324 
was considerably lower, at 27%. Further dermal investigations using 14C-radiolabelled 2-phenylethyl 325 
alcohol revealed that proportion of total substrate recovery was greater following repeat-dosing, 326 
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reaching 68.4%, primarily as the metabolite 2-phenylethylacetic acid, at the conclusion of a 9-day 327 
assessment. 328 
Short-to-medium chain carboxylic acids are well-absorbed orally, although owing to unfavourable 329 
physicochemical properties, they generally do not permeate the skin.[37] Depending upon chain 330 
length, they may be bound to albumin within the bloodstream, or incorporated into triglyceride 331 
structures. Participation in catabolic pathways is a common fate.[38] In vitro examination into the 332 
metabolism of specific, radio-labelled variants revealed that the predominant pathways were the 333 
oxidative breakdown into both shorter-chained derivatives and CO2, whilst overall urinary excretion 334 
was low.[39, 40] 335 
3.2.6. Metabolic similarity 336 
It can be assumed with high confidence that, due to the structural similarity, all esters analysed 337 
within this study will be subject to carboxylesterase enzyme-mediated initial hydrolysis which in turn 338 
yields both the aryl alcohol and alkyl carboxylic acid metabolites. Evidence suggests that such 339 
alcohols undergo a two-stage process of oxidation – first to their equivalent aldehyde and then 340 
further to the carboxylic acid – through transformations conducted respectively by alcohol and 341 
aldehyde dehydrogenase enzymes.[41] Conjugation of the resultant carboxylic acid to either glycine, 342 
glucuronic acid derivatives or L-glutamine produces metabolites excreted primarily in urine (refer to 343 
Supplementary Figure 1 for schematic representation). The alkyl carboxylic acids produced through 344 
hydrolysis are integrated as substrates within physiological processes. Following ligation to 345 
coenzyme A, translocation to the mitochondrion precedes catabolism through β-, α- or ω-oxidation 346 
pathways. Resulting acetyl-CoA units are incorporated into the citric acid cycle, from which water 347 
and CO2 are by-products. 348 
All esters and alcohols included show great similarity with regards to in silico toxicokinetics. Based 349 
upon simulators present within the OECD Toolbox v3.4, (rat liver S9 and skin metabolism), all 350 
derivatives are considered to be readily metabolised through safe pathways. Similar predictions 351 
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were observed with TIMES-SS (v. 2.28.), MetaPrint2D-React, SMARTCyp (v. 2.4.2.), and Meteor 352 
Nexus (v. 3.0.) (Lhasa Limited, UK) softwares – each of which may be described broadly as an “expert 353 
system”, drawing upon existing structure-activity knowledge in order to predict biotransformative 354 
fate (refer to Supplementary Table 6 for summary of outcomes, as available). 355 
 356 
3.2.7. In silico toxicodynamic similarity 357 
All aryl alkanoates and alcohols considered are highly similar with regards to in silico toxicodynamics. 358 
Category and subcategory consistency was established using the OECD QSAR Toolbox (v. 3.4.). 359 
Specifically, results from the mechanistic and endpoint profilers (data not shown) revealed none of 360 
the compounds possessed alerts indicative of potential toxicity. Moreover, all compounds are 361 
deemed Cramer Class I chemicals. In addition, none are classified as potential receptor binders by 362 
COSMOS (COSMOS profiler available at: http://knimewebportal.cosmostox.eu/webportal). No alerts 363 
were fired in Derek Nexus (v. 2.1.) (Lhasa Limited, UK), with the exception in two compounds 364 
associated with “irritation of gastrointestinal tract” (refer to Supplementary Table 6 for summary of 365 
outcomes, as available).  366 
3.2.8. High throughput toxicodynamic similarity 367 
Available ToxCast data were searched through the US EPA Chemistry Dashboard 368 
https://comptox.epa.gov/dashboard/ [accessed 10/10/2017]. Test results were recovered for five 369 
benzyl esters and benzyl alcohol, alongside five 2-phenylethyl esters and 2-phenylethyl alcohol (refer 370 
to Table 3 for additional detail). 371 
 372 
 373 
 374 
 375 
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Compound 
Assays 
run 
Active 
hits 
Assay ID Target family 
Benzyl alkanoate 
    Benzyl acetate 298 1 ACEA_T47D_80hr_Positive Nuclear receptor 
Benzyl propionate 276 1 ATG_DR5_CIS_dn Nuclear receptor 
Benzyl butyrate 276 0 
  Benzyl isobutyrate 163 0 
  Benzyl isovalerate 276 3 TOX21_NFkB_BLA_agonist_viability Cell cycle 
   
ATG_Ahr_CIS_dn DNA binding 
   
ATG_PXRE_CIS_up Nuclear receptor 
Benzyl alcohol 541 5 NVS_ENZ_oCOX2 Oxidoreductase 
   
ATG_PPRE_CIS_up Nuclear receptor 
   
ATG_RXRa_TRANS_up Nuclear receptor 
   
ATG_RXRb_TRANS_up Nuclear receptor 
   
ATG_NURR1_TRANS_up Nuclear receptor 
Phenylethyl alkanoate 
    2-Phenylethyl acetate 276 0 
  2-Phenylethyl isobutyrate 276 0 
  2-Phenylethyl propionate 113 3 TOX21_Aromatase_Inhibition Cytochrome 
   
TOX21_ARE_BLA_agonist_ratio DNA binding 
   
TOX21_PPARd_BLA_antagonist_ratio Nuclear receptor 
2-Phenylethyl butyrate 276 1 TOX21_NFkB_BLA_agonist_viability Cell cycle 
2-Phenylethyl hexanoate 276 2 TOX21_p53_BLA_p3_ch2 Background 
   
ATG_Ahr_CIS_dn DNA binding 
2-Phenylethyl alcohol 296 2 OT_ER_ERbERb_1440 Nuclear receptor 
      ATG_PPARg_TRANS_dn Nuclear receptor 
Table 3. Summary of output related to ToxCast screening of aryl alkyl alkanoates. 376 
 377 
 378 
Based on ToxCast results the benzyl, 2-phenylethyl and 3-phenpropyl alkanoates, as well as their 379 
corresponding alcohols, do not appear to be associated with specific toxicities. For the ten esters 380 
and more that 3,600 results in ToxCast, an active hit was reported for only eleven assays, a rate of 381 
0.33%. Moreover, there is no pattern in these positive responses. Similar results were observed for 382 
the two alcohol metabolites; specifically, of the over 1,000 results in ToxCast only seven active hits 383 
were reported, a rate of 0.63%.3.2.9. Plausibility of mechanistic similarity 384 
On account of the high levels of structural conformity evident for all category members, a shared 385 
general mode of action may be assumed. It is postulated that this is centred upon the metabolism of 386 
parent compounds to their shared primary aryl alcohol substituents, which themselves proceed to 387 
impart toxicity through a mechanism of unspecific basal cytotoxicity. Extrapolation of the concept of 388 
narcosis – a phenomenon held to arise as a consequence of reversible non-covalent interference 389 
with the structure and function of the phospholipid bilayers constituting cell membranes, and 390 
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further closely associated with the acute toxicity of such compounds – may be considered in order to 391 
rationalise the sub-chronic effects.[42, 43] 392 
There are several lines of evidence that support the hypothesis that all the analogues considered act 393 
in a similar manner, that is, through simple anaesthesia or basal cytotoxicity. Specifically, while there 394 
is no mammalian adverse outcome pathway for the hypothesised mode of action, it is generally 395 
accepted that the toxicity of saturated esters is based on their alcohol metabolite and thus is due to 396 
a non-specific narcotic effect.[6] There is both theoretical and biochemical evidence for the cell 397 
membrane functioning as the site of action for anaesthetic-like compounds such as saturated 398 
alcohols.[14, 15, 44] These findings are supported by animal data.[45-48] Narcosis, in the broadest sense, is 399 
the reversible, non-covalent disruption of hydrophobic interactions within membranes with a 400 
particular volume fraction, rather than molar fraction.[49] While the precise mechanism has yet to be 401 
elucidated, it is the accumulation of alcohols in cell membranes which leads to disturbance in 402 
cellular function. With repeated exposure, likelihood of cumulative damage to tissue within 403 
susceptible organ systems grows to constitute credible concern. 404 
McCloskey et al. reported an attempt to alter benzyl alcohols toxicity by using pyrazole and 405 
disulfiram to inhibit the activities of alcohol dehydrogenase and aldehyde dehydrogenase, 406 
respectively.[41] Treatment with pyrazole, before benzyl alcohol exposure, resulted in an increase in 407 
benzyl alcohol levels to 203% of controls concomitant with a marked increase in toxicity. Although 408 
pre-treatment with disulfiram led to benzaldehyde levels which were 368% of controls, toxicity was 409 
unchanged. These data imply that the acute toxicity of benzyl alcohol, which includes sedation, 410 
dyspnoea and loss of motor function is due to the alcohol itself and not to its metabolite, 411 
benzaldehyde. 412 
While an AOP for narcosis is under development 413 
(http://www.oecd.org/chemicalsafety/testing/projects-adverse-outcome-pathways.htm) no 414 
pathway has been evaluated. However, the basic premise of such a sequence (i.e., partitioning of 415 
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unreactive compounds into cellular membranes leading to decreased physiological performance) is 416 
consistent with the mode of action proposed in a previous read-across for saturated alcohols.[6] As 417 
previously noted, the ToxCast data show the aryl alkanoates and corresponding alcohols to be a 418 
seemingly innocuous group of compounds not consistently associated with receptor binding. 419 
The applicability of the mechanism to the primary aryl alcohols in this analysis can be inferred from 420 
the properties of related chemical species, including n-alkanols, supported by mammalian in vivo 421 
analysis.[6, 46] One such study indicated that administration of analogous compounds induces 422 
depressant effects within rodents, generally additive to those observed following co-treatment with 423 
the structurally-unrelated volatile anaesthetic desflurane.[14] Although evidently non-mammalian, 424 
further support for such hypotheses can be derived through consideration of the mechanism 425 
proposed to underpin alcohol-induced non-specific toxicity within aquatic species.[45] Conversely, the 426 
alkyl carboxylic acids liberated through hydrolysis are, irrespective of chain length, proposed to play 427 
no contributory role towards toxic effects. Their participation in catabolic pathways ensures their 428 
ready integration into physiological processes, whilst the major breakdown product, CO2, is excreted 429 
harmlessly. 430 
Assessment Factor Uncertainty Comment 
 
Hypothesis used for read-
across 
 
Low 
 
The hypothesis underpinning the read-across – namely that toxicity in aryl 
alkanoate esters emerges as a consequence of their rapid hydrolysis into 
aryl alcohol and carboxylic acid substituents, the former of which proceeds 
to stimulate adverse effects through a mechanism akin to basal cytotoxicity 
or non-polar narcosis – has convincing theoretical and experimental support 
from in vivo, in vitro and in silico toxicodynamic and toxicokinetic evidence. 
 
Structural similarity  
 
Low 
 
All compounds included within this study belong to the class of aryl alcohol 
unsaturated carboxylic acid esters. Compounds are subdivided into two 
categories, each composed of 13 esters alongside their common primary 
aryl alcohol constituent. Functional groups are consistent across all entries, 
with liability towards metabolism to toxicologically-relevant alcohol moiety 
universally conserved. A category is thus defined by structure of shared 
alcohol – either benzyl or 2-phenylethyl. Intra-category variation in 
molecular structure is dependent solely upon the length of carboxylic acid 
alkyl chain, which increases from C2 to C12. 
 
Similarity of 
physicochemical 
properties 
 
Low 
 
Structural variation within each respective category is defined solely by 
length of alkyl chain present upon the carboxylic acid functionality. As such, 
whilst experimentally-derived physicochemical properties are reported for 
only a comparatively small number of target compounds, variation in 
parameters such as melting point, boiling point, vapour pressure and 
solubility may be predicted reliably using existing in silico models. 
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Conservation of relevant functional groups across members further enables 
is also consistent with the variation in physicochemical properties. 
 
Similarity of toxicokinetic 
data 
 
Low to 
medium 
 
Despite paucity of experimental data, there is concordance in the ADME 
profiles of the esters and alcohols examined. This is evidence from in vivo 
and in vitro outcomes, which indicate the commonality of the key hydrolysis 
step, followed by both alcohol conjugation and excretion and carboxylic acid 
integration into catabolic pathways. 
 
Similarity of other 
supportive data 
 
Low 
 
Extensive in silico evidence, derived from a variety of established 
computational approaches, reveals commonality in toxicodynamic and 
toxicokinetic effects for all compounds.  
 
Number of analogues 
used for read-across 
 
 
 
 
 
 
Quality of target 
endpoint data used for 
read-across 
 
 
 
 
Similarity of target 
endpoint data 
 
 
 
 
 
 
 
Concordance and weight-
of-evidence of all data 
used in justifying 
hypothesis 
 
 
 
 
 
Overall uncertainty of 
read-across 
 
Low to 
medium 
 
 
 
 
 
 
Low 
 
 
 
 
 
 
Low 
 
 
 
 
 
 
 
 
 
Low 
 
 
 
 
 
 
 
 
Low 
 
Experimental toxicodynamic data were obtained for only one of the thirteen 
benzyl esters. Within the 2-phenylethyl category, this number falls to zero. 
Proposed common alcohol metabolites, from which relevant toxicological 
effects originate are, however, well characterised – in turn serving to 
mitigate the low number of toxicity data for source compounds. As a result, 
greater uncertainly (medium) is associated with the 2-phenylethyl 
constituents as compared to their benzyl derivatives (low). 
 
Where present, in vivo characterisation of toxicodynamic effects was 
performed using consistent methodology, in line with recognised and 
accepted protocol. Namely, this consisted of 90-day repeat-dose 
administration in rodents, either through oral or dermal route, in 
accordance with procedures corresponding to OECD Test Guidelines 408 or 
411.  
 
Within the single ester, benzyl acetate, for which experimental data for 
repeat-dose in vivo toxicity were available, general concordance was 
evident with respect to effect across species and sex. NOAELs of 250-500 
mg/kg/day were assigned, with higher susceptibility present within females. 
Benzyl and 2-phenylethyl alcohols similarly each induce toxicity within 
rodent species at moderately elevated dose. Neither short nor medium-
chained carboxylic acids exhibited signs of stimulating sub-chronic toxicity at 
doses below 1000 mg/kg/day. 
 
Consistency is present with respect to both in vivo and in vitro toxicokinetic 
and toxicodynamic data. Supported by predictions performed in silico, they 
each serve to provide weight to the hypothesis that the aryl alkanoate 
compounds investigated undergo swift metabolism to their toxicophoric 
alcohol and essential non-toxic carboxylic acid constituents, each of which 
proceed to undergo metabolism and excretion through shared pathways. As 
such, mitigation for the comparatively small number of toxicity data 
available for the source material may be assumed with confidence. 
 
Despite the necessity in extrapolating outcomes from a comparatively small 
pool of source data, robust theoretical backing – assisted in the form in 
silico screening – can be provided for the hypothesis that such toxic effects 
emerge through single shared common products of metabolism (aryl 
alcohols), themselves characterised through high quality and consistent 
experimental study. As such, it may be inferred with confidence that cross-
category consistency is present with respect to toxicological profile, and 
that minor physicochemical variance amongst members has minimal impact 
on toxicity. It should be noted that the wider data availability apparent 
across the benzyl ester category lends reduced uncertainty to predictions 
performed across it, relative to those within the 2-phenyethyl family. 
   
Table 4. Assessment of the read-across in terms of uncertainty, characterised in accordance with OECD IATA 431 
guidelines. 432 
 433 
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4. Statement of uncertainty 434 
Levels of confidence attributable to several aspects key to establishing the validity of the read-across 435 
are expressed in terms of OECD IATA “Uncertainty” rating, as detailed within Table 4.[8] Within each 436 
set considered, experimental toxicodynamic data may be found for only a comparatively small 437 
proportion of individual compounds (one benzylic alcohol ester and zero 2-phenylethyl alcohol 438 
esters each from thirteen, also shared alcohol constituents). Whilst this might appear insufficient for 439 
reliable prediction across such a large number of potential targets, the great similarity in structure 440 
between compounds ensures that an identical mechanism of action – one dependent upon swift 441 
enzyme-mediated hydrolysis to the toxicophoric aryl alcohol unit – may be assumed to be applicable 442 
throughout. Considering this mechanism further, it is necessary to discuss the potential influence 443 
which structural variations across the parent compounds might have with respect to their 444 
absorption and distribution. Although there are few experimental data, physicochemical properties, 445 
which vary with alkyl chain length, may be reliably predicted. Whilst it is feasible to presume that 446 
such subtle alterations in lipophilicity and volatility across the category are inconsequential due to 447 
the rapid activation towards the alcohol toxicophore, a level of uncertainty remains on account of 448 
the lack of experimental evidence directly confirming the properties of the longer chain analogues. 449 
Through adoption of a “worst case” approach, reading across directly from the aryl alcohol, such 450 
concerns may be allayed. Naturally, a heightened degree of doubt will continue to exist within the 2-451 
phenylethyl category on account of the comparative lack of direct evidence confirming, or otherwise, 452 
the behaviour of its members. 453 
Where present, the experimental assessments of toxicokinetic and toxicodynamic properties are 454 
themselves of high quality, lending credibility to the values and effects extrapolated across. The 455 
shared alcohols within the benzyl and 2-phenylethyl categories are notably well characterised, 456 
standing to provide dependable prediction of toxicokinetics and toxicodynamics across their 457 
respective esters with adoption of a “worst-case” reading. With respect to carboxylic acids, data are 458 
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recovered across a range of chain compositions extending to C12. As such, interpolation towards 459 
properties within intermediate-length analogues may be performed with confidence. 460 
 461 
5. Conclusion 462 
The outcomes presented illustrate the formulation of a read-across protocol for 90-day, repeat-dose 463 
toxicity within a series of aryl alcohol alkyl carboxylic acid esters, framed to comply with the 464 
guidelines within the OECD IATA scheme.[7] The nature of the principles underpinning the read-465 
across – namely that a category of similar compounds, possessing a minor structural variation 466 
accompanied by predictable alteration in physicochemical properties, produce toxicity upon 467 
activation to a shared toxicophoric species – is in accordance with Scenario 3 of the European 468 
Chemical Agency’s Read-Across Assessment Framework.[50] 469 
Two distinct sub-categories of esters were formed, unified by a shared aryl alcohol substituent and 470 
with variance within confined solely to the length of carboxylic acid alkyl chain. Levels of read-across 471 
certainty, and therefore OECD IATA “Uncertainty” ranking, differ only slightly between both, 472 
reducing with the availability of suitable experimental data attesting the properties of source 473 
compounds. High-quality in vivo assessments for both the toxicodynamic and toxicokinetic 474 
properties of benzyl alcohol and acetate were available from the literature. Conversely, whilst 2-475 
phenylethyl alcohol has been subject to wide examination, data relating its acetate are less robust. 476 
In order to provide necessary theoretical support, a mechanistic hypothesis was proposed – namely 477 
that the parent esters undergo rapid hydrolysis to their aryl alcohol and alkyl carboxylic acid units: 478 
the former inducing toxicity through a basal cytotoxicity, or non-polar narcosis, mechanism prior to 479 
metabolism and excretion, the latter being causative of, and contributory to, no adverse effect. On 480 
account of these shared characteristics, NOAEL values and specific effects noted for the alcohol can 481 
hence be expanded across its alkanoate category with confidence through adoption of a “worst-case” 482 
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approach. Such a methodology can be further extended between categories, with the great 483 
structural similarities in toxicophoric units permitting the inference of properties across benzyl and 484 
2-phenylethyl counterparts. Whilst some degree of uncertainty exists concerning the relatively small 485 
number of compounds for which experimental data may be recovered, and for the impact which the 486 
greater lipophilicity of category members with longer chain lengths might have upon their 487 
absorption and distribution, the quality of the data available, the similarity in chemical structure and 488 
the theoretical basis for the proposed shared mechanism are sufficient as they stand to support the 489 
plausibility and applicability of the approach adopted.  490 
Expansion of experimental evidence would have immediately obvious potential in enhancing the 491 
confidence in the read-across validity. Within the scope of this study, it would appear feasible to 492 
develop greater certainty in the existence of shared toxicokinetic profiles through extension in vitro 493 
assessment of ester hydrolysis susceptibility, as recorded in 2-phenylethyl acetate, so that it may 494 
encompass a wider range of category members.[27] More challenging, but at the same time of 495 
greater utility, would be performance of further repeat-dose in vivo toxicity analysis, perhaps over a 496 
shortened time-scale of 28 days, upon selected compounds. 497 
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 Table 1a: Comparison of Substance Identification, Structure and Chemical Classifications of Benzyl Derivatives 643 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
1 Benzyl acetate 140-11-4 c1ccccc1COC(=O)C 
 
C9H10O2 
2 Benzyl propionate 122-63-4 c1ccccc1COC(=O)CC 
 
C10H12O2 
3 Benzyl butyrate 103-37-7 c1ccccc1COC(=O)CCC 
 
C11H14O2 
4 Benzyl isobutyrate 103-28-6 c1ccccc1COC(=O)C(C)C 
 
C11H14O2 
O
O
O
O
O
O
O
O
30 
 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
5 Benzyl valerate 10361-39-4 c1ccccc1COC(=O)CCCC 
 
C12H16O2 
6 Benzyl isovalerate 103-38-8 c1ccccc1COC(=O)CC(C)C 
 
C12H16O2 
7 Benzyl hexanoate 6938-45-0 c1ccccc1COC(=O)CCCCC 
 
C13H18O2 
8 Benzyl heptanoate 5454-21-7 c1ccccc1COC(=O)CCCCCC 
 
C14H20O2 
O
O
O
O
O
O
O
O
31 
 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
9 Benzyl octanoate 10276-85-4 c1ccccc1COC(=O)CCCCCCC 
 
C15H22O2 
10 Benzyl nonanoate 6471-66-5 c1ccccc1COC(=O)CCCCCCCC 
 
C16H24O2 
11 Benzyl decanoate 42175-41-7 c1ccccc1COC(=O)CCCCCCCCC 
 
C17H26O2 
12 Benzyl undecanoate Not found c1ccccc1COC(=O)CCCCCCCCCC 
 
C18H28O2 
O
O
O
O
O
O
O
O
32 
 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
13 Benzyl dodecanoate 140-25-0 c1ccccc1COC(=O)CCCCCCCCCCC 
 
C19H30O2 
14 Benzyl alcohol 100-51-6 c1ccccc1CO 
 
C7H8O 
 644 
 645 
 646 
 647 
 648 
Table 1b: Comparison of Substance Identification, Structure and Chemical Classifications of 2-Phenylethyl Derivatives 649 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
O
O
OH
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ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
1 2-Phenylethyl acetate 103-45-7 c1ccccc1CCOC(=O)C 
 
C10H12O2 
2 2-Phenylethyl propionate 122-70-3 c1ccccc1CCOC(=O)CC 
 
C11H14O2 
3 2-Phenylethyl butyrate 103-52-6 c1ccccc1CCOC(=O)CCC 
 
C12H16O2 
4 2-Phenylethyl isobutyrate 103-48-0 c1ccccc1CCOC(=O)C(C)C 
 
C12H16O2 
O
O
O
O
O
O
O
O
34 
 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
5 2-Phenylethyl valerate 7460-74-4 c1ccccc1CCOC(=O)CCCC 
 
C13H18O2 
6 2-Phenylethyl isovalerate 140-26-1 c1ccccc1CCOC(=O)CC(C)C 
 
C13H18O2 
7 2-Phenylethyl hexanoate 6290-37-5 c1ccccc1CCOC(=O)CCCCC 
 
C14H20O2 
8 2-Phenylethyl heptanoate 5454-11-5 c1ccccc1CCOC(=O)CCCCCC 
 
C15H22O2 
O
O
O
O
O
O
O
O
35 
 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
9 2-Phenylethyl octanoate 5457-70-5 c1ccccc1CCOC(=O)CCCCCCC 
 
C16H24O2 
10 2-Phenylethyl nonanoate 57943-67-6 c1ccccc1CCOC(=O)CCCCCCCC 
 
C17H26O2 
11 2-Phenylethyl decanoate 61810-55-7 c1ccccc1CCOC(=O)CCCCCCCCC 
 
C18H28O2 
12 2-Phenylethyl undecanoate Not found c1ccccc1CCOC(=O)CCCCCCCCCC 
 
C19H30O2 
O
O
O
O
O
O
O
O
36 
 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
13 2-Phenylethyl dodecanoate Not found c1ccccc1CCOC(=O)CCCCCCCCCCC 
 
C20H32O2 
14 2-Phenylethyl alcohol 60-12-8 c1ccccc1CCO 
 
C8H10O 
 650 
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Table 1c: Comparison of Substance Identification, Structure and Chemical Classifications of Carboxylic Acids 655 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
O
O
OH
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ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
1 Acetic acid 
                        
64-19-7 OC(=O)C 
 
C2H4O2 
2 Propionic acid 
                         
79-09-4 OC(=O)CC 
 
C3H6O2 
3 Butyric acid 107-92-6 OC(=O)CCC 
 
C4H8O2 
4 Isobutyric acid 79-31-2 OC(=O)C(C)C 
 
C4H8O2 
OH
O
OH
O
OH
O
OH
O
38 
 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
5 Valeric acid 109-52-4 OC(=O)CCCC 
 
C5H10O2 
6 Isovaleric acid 503-74-2 OC(=O)CC(C)C 
 
C5H10O2 
7 Hexanoic acid 142-62-1 OC(=O)CCCCC 
 
C6H12O2 
8 Heptanoic acid 111-14-8 OC(=O)CCCCCC 
 
C7H14O2 
OH
O
OH
O
OH
O
OH
O
39 
 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
9 Octanoic acid 124-07-2 OC(=O)CCCCCCC 
 
C8H16O2 
10 Nonanoic acid 112-05-0 OC(=O)CCCCCCCC 
 
C9H18O2 
11 Decanoic acid 334-48-5 OC(=O)CCCCCCCCC 
 
C10H20O2 
12 Undecanoic acid 112-37-8 OC(=O)CCCCCCCCCC 
 
C11H22O2 
OH
O
OH
O
OH
O
OH
O
40 
 
ID Name CAS No: SMILES 2D Structure 
Molecular 
Formula 
13 Dodecanoic acid 143-07-7 OC(=O)CCCCCCCCCCC 
 
C12H24O2 
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Table 2a: Comparison of Physicochemical and Molecular Properties of Benzyl Derivatives1 658 
ID Name 
Molecular 
Weight [g/mol] 
Log Kow 
Vapor Pressure  
[Pa at 25°C] 
Densityc 
[g/cm3 
at 25°C] 
Melting 
Point [°C] 
Water 
Solubility 
[mg/L] 
Boiling 
Point [°C] 
1 Benzyl acetate 150.18* 1.96* 23.6* 1.1±0.1† -51.2* 3.1 x 104* 213* 
2 Benzyl propionate 164.21* 2.57† 17.5† 1.0±0.1† 10.6† 416.4† 220* 
3 Benzyl butyrate 178.23* 3.06† 6.51† 1.0±0.1† 21.44† 136† 239* 
4 Benzyl isobutyrate 178.23* 2.99† 5.70† 1.0±0.1† 10.84† 157.2† 241.5† 
5 Benzyl valerate 192.26* 3.55† 1.14† 1.0±0.1† 32.02† 44.15† 269.08† 
6 Benzyl isovalerate 192.26* 3.26* 4.74† 1.0±0.1† 21.57† 78.74† 245* 
7 Benzyl hexanoate 206.29* 4.05† 0.398† 1.0±0.1† 42.34† 14.26† 285.11† 
8 Benzyl heptanoate 220.31* 4.54† 0.144† 1.0±0.1† 52.39† 4.582† 300.23† 
9 Benzyl octanoate 234.34* 5.03† 0.0542† 1.0±0.1† 62.17† 1.467† 314.45† 
10 Benzyl nonanoate 248.37* 5.52† 0.0213† 1.0±0.1† 71.69† 0.4678† 327.76† 
11 Benzyl decanoate 262.4* 6.01† 8.79 x 10-3† 1.0±0.1† 80.95† 0.1487† 340.18† 
12 Benzyl undecanoate 276.24* 6.50† 3.75 x 10-3† 1.0±0.1† 90.02† 0.04716† 351.91† 
13 Benzyl dodecanoate 290.45* 6.99† 8.39 x 10-3† 0.9±0.1† 99.04† 0.01491† 363.52† 
14 Benzyl alcohol 108.14* 1.10* 12.5* 1.0±0.1† -15.2* 4.29 x 104* 205* 
1Values typically derived from https://pubchem.ncbi.nlm.nih.gov or EPISuite v4.1.. Experimental outcomes (denoted *) displayed in preference to predicted (denoted †) as 659 
available.  660 
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Table 2b: Comparison of Physicochemical and Molecular Properties of 2-Phenylethyl Derivatives1 661 
ID Name 
Molecular 
Weight [g/mol] 
Log Kow 
Vapor Pressure  
[Pa at 25°C] 
Densityc 
[g/cm3 
at 25°C] 
Melting 
Point [°C] 
Water 
Solubility 
[mg/L] 
Boiling 
Point [°C] 
1 2-Phenylethyl acetate 164.20* 2.30* 4.19* 1.0±0.1† -31.1* 0.711† 232.6* 
2 2-Phenylethyl propionate 178.23* 3.06† 6.86† 1.0±0.1† 21.44† 0.278† 238* 
3 2-Phenylethyl butyrate 192.26* 3.55† 1.14† 1.0±0.1† 32.02† 44.15† 269.08† 
4 2-Phenylethyl isobutyrate 192.26* 3.48† 3.63† 1.0±0.1† 21.57† 51.02† 250* 
5 2-Phenylethyl valerate 206.29* 4.05† 0.398† 1.0±0.1† 42.34† 14.26† 285.11† 
6 2-Phenylethyl isovalerate 206.29* 3.97† 0.907† 1.0±0.1† 24.45† 16.47† 275.55† 
7 2-Phenylethyl hexanoate 220.31* 4.54† 0.144† 1.0±0.1† 52.39† 4.582† 300.23† 
8 2-Phenylethyl heptanoate 234.34* 5.03† 0.0542† 1.0±0.1† 62.17† 1.467† 314.45† 
9 2-Phenylethyl octanoate 248.37* 5.52† 0.0213† 1.0±0.1† 71.69† 0.4678† 327.16† 
10 2-Phenylethyl nonanoate 262.4* 6.01† 8.79 x 10-3† 1.0±0.1† 80.95† 0.1487† 340.18† 
11 2-Phenylethyl decanoate 276.42* 6.50† 3.75 x 10-3† 1.0±0.1† 90.02† 0.04716† 351.91† 
12 2-Phenylethyl undecanoate 290.45* 6.99† 1.60 x 10-3† 1.0±0.1† 99.04† 0.01491† 363.52† 
13 2-Phenylethyl dodecanoate 304.48* 7.48† 6.78 x 10-4† 0.9±0.1† 108.06† 4.70 x 10-3† 375.12† 
14 2-Phenylethyl alcohol 122.16* 1.36* 11.6* 1.0±0.1† -27.1* 2.22 x 104* 218.2* 
1Values typically derived from https://pubchem.ncbi.nlm.nih.gov or EPISuite v4.1.. Experimental outcomes (denoted *) displayed in preference to predicted (denoted †) as available.  662 
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Table 2c: Comparison of Physicochemical and Molecular Properties of Carboxylic Acids1 663 
ID Name 
Molecular 
Weight [g/mol] 
Log Kow 
Vapor Pressure  
[Pa at 25°C] 
Densityc 
[g/cm3 
at 25°C] 
Melting 
Point [°C] 
Water 
Solubility 
[mg/L] 
Boiling 
Point [°C] 
1 Acetic acid 60.05* -0.11* 2.09 x 103* 1.1±0.1† 16.6* 1.00 x 106* 117.9* 
2 Propionic acid 74.08* 0.33* 471* 1.0±0.1† -20.07* 1.57 x 105* 141.1* 
3 Butyric acid 88.11* 0.79* 220* 1.0±0.1† -5.70* 6.00 x 104* 163.7* 
4 Isobutyric acid 88.11* 0.94* 241* 1.0±0.1† -46.0* 1.67 x 105* 154.4* 
5 Valeric acid 102.13* 1.39* 26.1* 1.0±0.1† -34.0* 2.40 x 104* 186.1* 
6 Isovaleric acid 102.13* 1.16* 58.7* 1.0±0.1† -29.3* 4.70 x 104* 176.5* 
7 Hexanoic acid 116.16* 1.92* 5.8* 1.0±0.1† -3.00* 1.03 x 104* 205.2* 
8 Heptanoic acid 130.19* 2.42* 1.43* 0.9±0.1† -7.30* 2.82 x 103* 222.2* 
9 Octanoic acid 144.22* 3.05* 0.495* 0.9±0.1† 16.3* 789* 239* 
10 Nonanoic acid 158.24* 3.42* 0.22* 0.9±0.1† 12.3* 284* 254.5* 
11 Decanoic acid 172.27* 4.02* 4.88 x 10-3* 0.9±0.1† 31.9* 61.8* 268.7* 
12 Undecanoic acid 186.3* 4.42* 0.508* 0.9±0.1† 28.6* 52.2* 280* 
13 Dodecanoic acid 200.32* 4.6* 2.13 x 10-3* 0.9±0.1† 43.2* 4.81* 298.9* 
1Values typically derived from https://pubchem.ncbi.nlm.nih.gov or EPISuite v4.1.. Experimental outcomes (denoted *) displayed in preference to predicted (denoted †) as available.  664 
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            Table 3: Comparison of Experimental Toxicodynamic Information 665
Name In Vivo and In Vitro Toxicodynamic Data 
 
 
 
 
 
Benzyl acetate 
Benzyl acetate has a 13-week gavage GLP study for subchronic repeated-dose toxicity conducted on 10 F344 rats/sex/dose 
administered 0, 62.5, 125, 250, 500, or 1,000 mg/kg test material, benzyl acetate in corn oil for 5 days a week.[1] Tremor, ataxia 
and sluggishness were reported among the 500 mg/kg/day females and animals of either sex at 1000 mg/kg/day. The body 
weights among the high dose group animals were significantly lower than the control group animals. The NOAEL was 
determined to be 500 mg/kg/day for males and 250 mg/kg/day for females based on observed clinical signs of tremor and ataxia 
among higher dose group animals.[1] 
In another GLP study, benzyl acetate was administered via gavage to 10 B6C3F1 mice/sex/dose for 13-weeks. The animals were 
administered benzyl acetate at doses of 0, 62.5, 125, 250, 500, or 1,000 mg/kg for male mice and 0, 125, 250, 500, 1,000, and 
2,000 mg/kg for female mice using corn oil as the vehicle. Mortality among the high dose females was reported. Compound-
related clinical signs observed in high-dose mice included trembling, inactivity, labored breathing and lower body temperature 
among high dose group animals. The NOAEL for repeated dose toxicity was determined to be 500 mg/kg bw/day based on 
mortality and clinical signs of tremor and inactivity.[1] 
Also during a 2-year carcinogenicity study conducted on rats and mice, there was no evidence of carcinogenicity among animals 
treated with benzyl acetate up to the highest dose tested.[1[ 
The most conservative NOAEL of 250 mg/kg/day was selected for the repeated dose toxicity endpoint. 
2-Phenylethyl 
acetate 
No experimental data. 
 
 
 
 
 
Benzyl alcohol 
 
Benzyl alcohol has a 13-week gavage GLP study for subchronic repeated-dose toxicity conducted in F344/N rats and B6C3F1 
mice.[2] Groups of 10 animals/sex/species/dose were gavaged with 0, 50, 100, 200, 400, or 800 mg/kg bw/d benzyl alcohol in a 
corn oil vehicle 5 days/week for 13 consecutive weeks. Observations included mortality, body weight, clinical signs, necropsy 
and selected histopathology. Eight of 10 male rats dosed at 800 mg/kg bw/d died during weeks 7 and 8; four of these deaths 
were described as gavage related. Rats dosed with 800 mg/kg bw/d exhibited clinical signs indicative of neurotoxicity including 
staggering, respiratory difficulty, and lethargy. Hemorrhages occurred around the mouth and nose, and there were histologic 
lesions in the brain, thymus, skeletal muscle, and kidney. In mice, deaths were scattered among all dose groups, but none 
occurred in vehicle controls. 
Four male and six female mice died after being dosed; all deaths but one were described as gavage related. Staggering after 
dosing also occurred the first 2 weeks of the studies in mice dosed at 800 mg/kg bw/d. Some of the deaths in rats and mice may 
have been caused by a combination of the gavage procedure and chemical toxicity, since there was evidence that benzyl alcohol 
induced neurotoxic effects. There were reductions in relative weight gain in male rats dosed at 800 mg/kg bw/d, in female rats 
dosed with 200, 400, and 800 mg/kg bw/d, in male mice dosed with 400 and 800 mg/kg bw/d, and in female mice dosed with 
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200, 400, and 800 mg/kg bw/d.[2] 
No notable changes in body weight gain or compound related histopathologic lesions were observed in rats or mice from the 
lower dose groups. The NOAEL for both rats and mice was determined to be 100 mg/kg bw/d.[2] 
 
2-Phenylethyl 
alcohol 
Findings from 13-week dermal repeated-dose studies in rats at at 0, 0.25, 0.5, 1.0 and 2.0 ml/kg bw/d (≈ 250, 500, 1000, and 
2000 mg/kg bw/d) 2-phenylethyl alcohol.[3] Based on reduction in body weight and body weight gains in the two highest dose 
groups, the dermal 90-day repeated-dose NOAEL of 2-phenylethyl alcohol was 0.50 ml/kg bw/d (i.e., 500 mg/kg bw/d).[3] 
 
 
 
 
 
 
Short- and 
medium-chain 
carboxylic acids 
In a 90-day diet study, rats were dosed with 0 or 0.62%, 1.25%, 2.5%, or 5% (≈ 312, 625, 1,250 or 2,500 mg/kg bw/d) propionic 
acid.[4] During the administration interval, there was no mortality and no clinical signs of toxicity. Food consumption was slightly 
reduced in males in the high dose group and by the end of the study, mean body weights in this group were reduced by 6% 
relative to controls. There were no significant changes in hematology or clinical chemistry parameters that could be attributed to 
the test material. There were no differences in absolute organ weights in treated groups relative to controls. Relative kidney 
weights were decreased in high dose males (12%). In high dose females, there was an increase in the relative weights of the 
heart (5%) and liver (9%). Examination of tissues revealed no lesions except point-of-contact (mucosa of the forestomach) 
changes included acanthosis, hyperkeratosis, and proliferation of the epithelium in the high treatment group. These changes 
were not observed in the post-exposure recovery group, and there were no differences in relative or absolute organ weights. 
The NOAEL value for local and systemic effects of propionic acid was determined to be ≈1,250 and ≈2,500 mg/kg bw/d for male 
and female rats, respectively.[4] 
Amoore et al. (1978) examined 90-day repeated-dose toxicity of isovaleric acid in a rat feeding study with 0, 5% and 10% (0, 
≈5,000 and ≈10,000 mg/kg bw/d) neutralised isovaleric acid in the diet.[5] In a pilot study with 10%, the food intake was 
significantly reduced, rats lost significantly weight, and one rat dies. No effects were seen in the main study, 5% for the 
parameters examined (i.e., food consumption, bodyweight development, organ weights, haematology, blood chemistry, 
urinalysis, and histopathology of 35 organs). The exception was a more basic urine in treated rats compared to controls (pH 8.4 
versus 7.2). Based on these finding, the NOAEL value for neutralised isovaleric acid is 5% in diet or ≈5000 mg/kg bw/d.[5] 
Fitzhugh et al. (1960) examined the 18-week repeated-dose toxicity of dodecanoic acid in a feeding study with 10% (≈10,000 
mg/kg bw/d) in the diet.[6] No clinical signs and no mortality were noted. No adverse effects on weight gain. Moreover, no 
significant differences between the controls and test animals were noted in either organ weight parameters or histopathology. 
Based on these finding the NOAEL for dodecanoic acid is ≈10,000 mg/kg bw/d.[6] 
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            Table 4: Comparison of Experimental Toxicokinetic Information 709
Name In Vivo and In Vitro Toxicokinetic Data 
 
 
 
 
 
 
 
 
 
 
Benzyl acetate 
Regardless of route of exposure, the metabolism of benzyl acetate proceeds by hydrolysis to benzyl alcohol, the bulk of which is 
oxidised to benzoic acid before undergoing conjugation to yield hippuric acid or glucuronide.[1-5] Benzyl acetate administrated to 
rats and mice dosed via gavage or feed is rapidly hydrolysed to benzyl alcohol and then oxidised to benzoic acid and mainly 
excreted in the urine as hippuric acid.[1] 
After gavage administration of benzyl acetate in corn oil at 500 mg/kg bw (rats) and 1000 mg/kg bw (mice), high benzoic acid 
plasma concentrations were observed. In contrast, much lower benzoic acid plasma concentrations were found after feed 
administration at (10,800 ppm for rats and 2,700 ppm for mice (≈ 615 mg/kg bw/d for rats and ≈ 850 mg/kg bw/d for mice). 
Although the daily doses of benzyl acetate are comparable bolus gavage administration effectively saturated the benzoic acid 
elimination pathway whereas dosed feed administration did not. In contrast, hippuric acid plasma concentrations were similar 
after both gavage and dosed feed administration due to the depletion of the glycine supply pool2. These differences may be 
related to the concentration of intermediate (benzaldehyde) generated, which is postulated to be higher in the gavage study 
owing to the higher input of benzyl acetate.[2] 
Other results indicate changes in minor routes of metabolism and excretion of benzyl acetate occur with age, but formation of 
hippuric acid from benzyl acetate is not affected by aging.[3] 
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Following dermal administration of neat methylene-14C-benzyl acetate compound to rats, 28-48% of the dose was recovered 
from the application site.[4] Similarly, 28-46% was absorbed and excreted in the 0-24-hr urine. Excretion of 14C in the urine over 
0-24 hours accounted for ≈ 95% of absorbed 14C with <4% of the dose present in the carcass at the end of the experiments. The 
total recovery of radioactivity was 79-84%. The major urinary metabolite (≈95%) was hippuric acid; other metabolites included 
much smaller amounts of benzoyl glucuronide, benzoic acid and benzylmercapturic acid.[4] While dermal absorption of benzyl 
acetate is incomplete, there is significant penetration through the skin, which is related to the concentration applied. The failure 
to obtain a complete recovery of dermally applied 14C is most likely due to loss by evaporation.[5] 
The various metabolic pathways appear to be solely involved in the detoxification of benzyl acetate.[1-5] 
 
Benzyl alcohol 
Humans, rabbits and rats readily oxidise benzyl alcohol to benzoic acid, which is subsequently conjugated with glycine prior to 
being rapidly eliminated as hippuric acid in the urine.[6] Within six hours after the oral administration of 0.40 g benzyl alcohol/kg 
of body weight, rabbits eliminated 65.7% of the dose as hippuric acid in the urine.[7] Metabolites identified in the urine of rabbits 
given an oral dose of 0.25 g/kg benzyl alcohol are chiefly glycine conjugate (74%) and glucosiduronic acid (14%).[8] 
 
2-Phenylethyl 
acetate 
The in vitro potential for hydrolysis of 16 esters including 2-phenylethyl acetate was examined.[9] Hydrolysis in rat liver and small 
intestinal tissue preparations, as well as artificial pancreatic juice and artificial gastro-intestinal juices followed first order rate 
kinetics. The tissue rates (liver tissue > intestinal mucosal tissue) showed that esters hydrolyse much more readily in tissues than 
with artificial juices.[9] 
 
2-Phenylethyl 
alcohol 
The toxicokinetics of 2-phenylethyl alcohol has been extensively studied.[10] In rats and rabbits 2-phenylethyl alcohol is rapidly 
and extensively absorbed, oxidise to 2-phenylacetic acid and excreted.[11] In rats, following oral and dermal administration, 
approximately 70% and 27%, of the administrated doses was eliminated in urine as 2-phenylacetic acid and its conjugates, 
respectively. The absorption rate by dermal administration is lower due to probably to evaporation and loss in dressing. The 
metabolic clearance is seemed to be reduced at higher plasma concentration due to capacity-limited elimination processes. The 
absorption and disposition of 14C-2-phenylethyl alcohol was examined in rats after single and repeated dermal application. After 
single dermal doses at 0.14 ml/kg means of 80.7 and 1.3% dose were excreted in urine and faeces, respectively. After 5 repeated 
dermal doses at 0.14 ml/kg, means of 68.6 and 1.1% of the cumulative dose were recovered from urine and faeces, respectively, 
during 216 hrs after the first dose. After repeated doses, means of 24.2 and 1.2% dose were recovered from skin and dressing; 
After repeated doses, total recovery was 68.4% dose as compared to 44.4% after a single dose. This difference was contributed 
to differences due to evaporation. Radioactivity was detected in a variety of organs/tissues. The major metabolite corresponded 
to 2-phenaceturic acid and accounted for about 80 of the urinary radioactivity.[11] While some urinary radioactivity corresponded 
to hippuric acid and 2-phenylacetic acid, very little corresponded to 2-phenylethyl alcohol.[11] In rabbits, half the dose was 
recovered, mainly from the urine. The remaining dose was lost probably due to evaporation. In rabbits, the initial stage in the 
biotransformation of 2-phenylethyl alcohol (oxidation to 2-phenylacetic acid) was similar to that in rats and humans. 
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Short- and 
medium-chain 
carboxylic acids 
The absorption, distribution, metabolism and elimination of short- and intermediate- chain carboxylic acids are well-studied.[12] 
Carboxylic acids are absorbed from the GI tract by different uptake mechanisms depending on the chain length. Short- and 
medium-chain fatty acids (C1 - C12) are rapidly absorbed via intestine capillaries into the blood stream. Due to physicochemical 
properties such as melting temperature, solubility and polarity, fatty acids are in general poorly absorbed through skin. Short-
chain acids are taken up and transported complexed to albumin; medium-chain acids are esterified with glycerol to 
triacylglycerides and packaged in chylomicrons. The most significant oxidation pathway of carboxylic acids is the β-oxidation 
pathway leading to H2O and CO2, but other pathways for acid catabolism include α- and ω-oxidation.[13]  Under normal 
physiological conditions, carboxylic acids are not expected to be excreted to any significant amount in the urine or faeces.[13] 
Results from in vitro experiments where [1-13C]butyric acid was incubated with slices of rat liver from fasted rats for two hours at 
pH 7.3 and 37.5°C have been reported14. In two experiments, butyric acid was utilised to 51 and 32% respectively. The major in 
vitro metabolites of butyric acid included respiratory CO2 (13.5 and 12.3%), acetoacetic acid (35.7 and 45.8%) and hydroxybutyric 
acid (11.7 and 9.3%).[14] 
Investigation of the metabolic fate of isobutyric acid in rats following a single gavage administration of radiolabelled [1-
14C]isobutyric acid were reported.[15]  Isobutyric acid was readily absorbed after oral application and rapidly excreted in expired 
air (i.e., peak plasma levels after 0.5 to 1 hr). In the first 4 hours after dosing, 67 to 83% of the administered dose was excreted 
as CO2 in expired air. Unchanged isobutyric acid was less than 0.1%. The recovery of radioactivity in the breath at 48 hr was 90.1 
to 96.7%. Radioactivity excreted in urine (48hr) ranged from 3.21 to 4.61%, while faecal radioactivity was less than 1.0% of the 
dose.[15] 
 710 
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            Table 5: Summary of in silico Toxicodynamic Screening Outcomes 754
52 
 
 755 
Name 
Cramer 
classification 
OECD 
QSAR 
Toolbox 
COSMOS 
profiling 
Derek 
Nexus 
Benzyl alkanoate esters* Class I No alert No alert No alert 
Benzyl alcohol Class I No alert No alert 
Irritation  
GI tract 
2-Phenylethyl alkanoate esters* Class I No alert No alert No alert 
2-Phenylethyl alcohol Class I No alert No alert 
Irritation  
GI tract 
                                                    * Denotes all considered aryl alcohol esters within category, from acetate to 756 
dodecanoate. 757 
 758 
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            Table 6: Summary of in silico Toxicokinetic and Metabolic Screening Outcomes 761
 762 
Name 
OECD QSAR Toolbox MetaPrint 
2D-React 
TIMES-SS 
Meteor 
Nexus 
Rat liver S9 Skin metabolism 
Benzyl alkanoate esters* 
Benzyl alcohol 
Benzoic acid 
Benzaldehyde 
Carboxylic acid 
Benzyl alcohol 
Carboxylic acid 
Not 
available† 
Not 
available† 
Not 
available† 
Benzyl alcohol 
Benzoic acid 
Benzaldehyde 
Benzoic acid 
Benzaldehyde 
Not 
available† 
Not 
available† 
Not 
available† 
2-Phenylethyl alkanoate esters* 
2-Phenylethyl alcohol 
2-Phenylacetic acid 
2-Phenylacetaldehyde 
2-Keto-2-phenylethyl alcohol 
2-Hydroxy-2-phenylethyl alkanoate 
2-Keto-2-phenylethyl alkanoate 
Carboxylic acid 
2-Phenylethyl alcohol 
Carboxylic acid 
Not 
available† 
Not 
available† 
Not 
available† 
2-Phenylethyl alcohol 
2-Phenylacetic acid 
2-Phenylacetaldehyde 
4-Hydroxyphenylethanol 
3,4-Dihydroxyphenylethanol 
2-Phenylacetic acid 
2-Phenylacetaldehyde 
Not 
available† 
Not 
available† 
Not 
available† 
* Denotes all considered aryl alcohol esters within category, from acetate to dodecanoate. 763 
† Data not presented owing to proprietary nature of software. 764 
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Figure 1. Schematic representation of metabolic pathways concerning benzyl alcohol 767 
esters 768 
 769 
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 771 
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